FOXP3 expression and nodal metastasis of breast cancer

Cellular Oncology

Volumn 36, Issue 5, 2013, Pages 405-409

  Gökmen Polar, Yesim ^a   Thorat, Mangesh A ^a   Sojitra, Payal ^a   Saxena, Rashmil ^a   Badve, Sunil ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Breast cancer; FOXP3; Immune response; Sentinel node; Th1; Th2; Treg; Tregulatorycells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SAMPLE SIZE; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE METASTASIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 84892698604     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0147-3     Document Type: Article

References (30)

1. T.R. Mosmann, R.L. Coffman, TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989)
2. J.I. Ellyard, L. Simson, C.R. Parish, Th2-mediated anti-tumour immunity: Friend or foe? Tissue Antigens 70, 1-11 (2007)
3. H.Murakami, H. Ogawara,H.Hiroshi, Th1/Th2 cells in patientswith multiple myeloma. Hematology 9, 41-45 (2004)
4. A.M. Thornton, E.M. Shevach, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998)
5. R.M. Lopez, M. Moser, Dendritic cell subsets and the regulation of Th1/Th2 responses. Sem. Immunol. 13, 275-282 (2001)
6. R.B. Effros, Replicative senescence of CD8 T cells: Potential effects on cancer immune surveillance and immunotherapy. Cancer Immunol. Immunother. 53, 925-933 (2004)
7. Z. Fehervari, S. Sakaguchi, CD4+ Tregs and immune control. J. Clin. Invest. 114, 1209-1217 (2004)
8. M. Dougan, G. Dranoff, Immune therapy for cancer. Annu. Rev. Immunol. 27, 83-117 (2009)
9. S. Hori, T. Nomura, S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057- 1061 (2003)
10. B.K. Halak, H.C. Maguire Jr., E.C. Lattime, Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. Cancer Res. 59, 911-917 (1999)
11. F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, H. Fujii, Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin. Cancer Res. 9, 4404-4408 (2003)
12. C. Rieser, R. Ramoner, L. Holtl, H. Rogatsch, C. Papesh, A. Stenzl, G. Bartsch,M. Thurnher,Mature dendritic cells induce T-helper type- 1-dominant immune responses in patients with metastatic renal cell carcinoma. Urol. Int. 63, 151-159 (1999)
13. J.D. Fontenot, M.A. Gavin, A.Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336 (2003)
14. S. Sakaguchi, The origin of FOXP3-expressing CD4+ regulatory T cells: Thymus or periphery. J. Clin. Invest. 112, 1310-1312 (2003)
15. M. Gobert, I. Treilleux, N. Bendriss-Vermare, T. Bachelot, S. Goddard-Leon, V. Arfi, C. Biota, A.C. Doffin, I. Durand, D. Olive, S. Perez, N. Pasqual, C. Faure, I. Ray-Coquard, A. Puisieux, C. Caux, J.-Y. Blay, C. Ménétrier-Caux, Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 69, 2000-2009 (2009)
16. A. Merlo, P. Casalini, M.L. Carcangiu, C. Malventano, T. Triulzi, S. Mènard, E. Tagliabue, A. Balsari, FOXP3 expression and overall survival in breast cancer. J. Clin. Oncol. 27, 1746-1752 (2009)
17. M. Ohara, Y. Yamaguchi, K. Matsuura, S. Murakami, K. Arihiro,M. Okada, Possible involvement of regulatory Tcells in tumor onset and progression in primary breast cancer. Cancer Immunol. Immunother. 58, 441-447 (2009)
18. E.G. Mansour, P.M. Ravdin, L. Dressler, Prognostic factors in early breast carcinoma. Cancer 74, 381-400 (1994)
19. A.E. Giuliano,D.M. Kirgan, J.M. Guenther, D.L.Morton, Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220, 391-398 (1994). discussion 398-401
20. D.N. Krag, D.L. Weaver, J.C. Alex, J.T. Fairbank, Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 2, 335-339 (1993). discussion 340
21. D.L. Morton, D.R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, F.K. Storm, L.J. Foshag, A.J. Cochran, Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127, 392-399 (1992)
22. N.J. Poindexter, A. Sahin, K.K. Hunt, E.A. Grimm, Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast Cancer Res. 6, R408-R415 (2004)
23. R.R. Huang, D.-R. Wen, J. Guo, A.E. Giuliano, M. Nguyen, R. Offodile, S. Stern, R. Turner, A.J. Cochran, Selective modulation of paracortical dendritic cells and T-lymphocytes in breast cancer sentinel lymph nodes. Breast J. 6, 225-232 (2000)
24. S. Ishigami, S. Natsugoe, Y. Uenosono, Y. Hata, A. Nakajo, F. Miyazono, M. Matsumoto, S. Hokita, T. Aikou, Infiltration of antitumor immunocytes into the sentinel node in gastric cancer. J. Gastrointest. Surg. 7, 735-739 (2003)
25. J. Schule, L. Bergkvist, L. Hakansson, B. Gustafsson, A. Hakansson, Down-regulation of the CD3-zeta chain in sentinel node biopsies from breast cancer patients. Breast Cancer Res. Treat. 74, 33-40 (2002)
26. K. Matsuura, Y. Yamaguchi, H. Ueno, A. Osaki, K. Arihiro, T. Toge, Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer 106, 1227-1236 (2006)
27. A.S. Mansfield, P.S. Heikkila, A.T. Vaara, K.A. von Smitten, J.M. Vakkila, M.H. Leidenius, Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 9, 231 (2009)
28. K. Matsuura, Y. Yamaguchi, A. Osaki, M. Ohara, R. Okita, A. Emi, S. Murakami, K. Arihiro, FOXP3 expression of micrometastasispositive sentinel nodes in breast cancer patients. Oncol. Rep. 22, 1181-1187 (2009)
29. R. Nakamura, M. Sakakibara, T. Nagashima, T. Sangai, M. Arai, T. Fujimori, S. Takano, T. Shida, Y. Nakatani, M. Miyazaki et al., Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer. Eur. J. Cancer 45, 2123-2131 (2009)
30. S.P.L. Leong, M. Peng, Y.M. Zhou, J.E. Vaquerano, J.W.C. Chang, Cytokine profiles of sentinel lymph nodes draining the primary melanoma. Ann. Surg. Oncol. 9, 82-87 (2002)